Today: 22 March 2026
Subscribe
Browse Category

NASDAQ:SLRX 12 November 2025

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals priced a $7 million underwritten public offering, with closing contingent on its merger with Decoy Therapeutics. The deal includes common shares, pre-funded warrants, and fixed-price Series A and B warrants. Shares plunged up to 51% Tuesday after the financing news, then rebounded over 50% pre-market and up to 65% intraday today. The merger is expected to close around November 12, 2025.
12 November 2025
···

Stock Market Today

  • US Stocks Fall as Iran War Drags On, Rate Hike Risks Rise, AI Waits for Proof
    March 22, 2026, 3:19 PM EDT. US equities ended lower for a second straight week with the Dow falling 1%, S&P 500 down 1.5%, and Nasdaq dropping 2% on Friday, wiping out 2026 gains amid escalating war in Iran. The conflict disrupts global energy, pushing Brent crude above $107 and WTI near $98 per barrel. Investors eye economic data for signs on inflation and labor after Fed Chair Powell's hawkish tone. Key releases include University of Michigan inflation expectations and industrial readings from S&P Global and the Kansas City Fed. Corporate earnings from Jefferies and Carnival are in focus this week. The energy standoff at the Strait of Hormuz raises geopolitical tensions, with control over this crucial passage uncertain, influencing market jitters and oil prices.
Go toTop